ZIM Laboratories to Invest in European, GCC Subsidiaries

MT Newswires Live
2025/03/31

ZIM Laboratories (NSE:ZIMLAB, BOM:541400) board approved an investment of up to 400,000 euros in its wholly owned subsidiary, SIA ZIM Laboratories, to support business expansion in Europe, according to an Indian bourse filing on Friday.

The company's shareholding in the subsidiary remains unchanged at 100%, the filing said.

Additionally, ZIM Laboratories FZE, a wholly owned subsidiary of ZIM Laboratories, will invest up to 466,000 Emirati Dirham in its step-down subsidiary, ZIM Scientific Office, to support growth in the GCC region, the filing added.

The investment does not alter ZIM Laboratories FZE's full ownership of the entity.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10